醫(yī)學英語 Medical English Writing(2) writing a research paper 學習資料_第1頁
醫(yī)學英語 Medical English Writing(2) writing a research paper 學習資料_第2頁
醫(yī)學英語 Medical English Writing(2) writing a research paper 學習資料_第3頁
醫(yī)學英語 Medical English Writing(2) writing a research paper 學習資料_第4頁
醫(yī)學英語 Medical English Writing(2) writing a research paper 學習資料_第5頁
已閱讀5頁,還剩53頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

MedicalEnglishWritingMay,2015Assignment(Chapter1)I1.AlightandelectronmicroscopicstudyoftwocasesofprimarysarcomaofheartPrimarysarcomaofheart:Alightandelectronmicroscopicstudyoftwocases光鏡和電鏡研究兩例原發(fā)性心臟肉瘤2.ExperimentalstudyoflasersurgeryoftheliverLasersurgeryoftheliver:Anexperimentalstudy肝臟的激光手術(shù)的實驗性研究/肝臟的激光手術(shù):一項實驗性研究3.Areportof60casesofprimaryvaginalcarcinomaPrimaryvaginalcarcinoma:Areportof60cases60例原發(fā)性陰道癌報告Assignment(Chapter1)4.Fifteenyears’clinicalexperiencewithcarcinomaofthepancreasCarcinomaofthepancreas:Fifteenyears’

clinicalexperience胰腺癌的15年臨床經(jīng)驗5.Carcinoembryonicantigen(癌胚抗原)inbreastcancertissueisausefulprognosticindicatorCarcinoembryonicantigeninbreastcancertissue:Ausefulprognosticindicator乳腺癌組織中的癌胚抗原——一種有用的預后指標Assignment(Chapter1)II1.Circulatoryfailureofmetastaticcarcinomaofthe

lungCirculatoryfailureinmetastaticcarcinomaofthe

lung

肺癌轉(zhuǎn)移中的循環(huán)衰竭2.Evaluationofetiologyofliverdiseaseinrenal-transplantpatientsEtiologyofliverdiseaseinrenal-transplantpatients

腎移植患者的肝病病因Assignment(Chapter1)3.Diabetesaftertheinfectioushepatitis:Afollow-

upstudyDiabetesafterinfectioushepatitis:Afollow-up

study

傳染性肝炎繼發(fā)糖尿病患者的隨訪研究4.Theuseofradioactiveiodineattheevaluationof

thyroidnodulesUseofradioactiveiodineintheevaluationof

thyroidnodules

用免疫活性碘評估甲狀腺結(jié)節(jié)Assignment(Chapter1)5.Diagnosisofpulmonarytuberculosisinflexible

fiberopticbronchoscopy(可曲光學纖維支氣管鏡

檢法)Diagnosisofpulmonarytuberculosisbyflexible

fiberoptic

bronchoscopyOr:Flexiblefiberopticbronchoscopy

in

the

diagnosis

of

pulmonarytuberculosis

用可曲光學纖維支氣管鏡檢法診斷肺結(jié)核Assignment(Chapter1)III.1.革蘭氏陰性菌休克169例分析Analysisof169casesofshockcausedbygram-

negativemicroorganisms(Shockcausedbygram-negativemicroorganisms:

Analysisof169cases)2.腫瘤患者化療前體重下降對預后的影響Prognosticeffectofweightlosspriorto

chemotherapyincancerpatients(Influenceof

weightlosspriortochemotherapyonprognosis

incancerpatient)Assignment(Chapter1)3.原發(fā)性肝癌二級預防的隨機分組前瞻性研究Secondarypreventionofprimarylivercancer:

Arandomizedcontrolledprospectivestudy4.放射免疫法測定血清17-羥孕酮以診斷與治療

先天性腎上腺增生Applicationofserum17-OH-progesterone

radioimmunoassaytothediagnosisand

managementofcongenitaladrenalhyperplasiaAssignment(Chapter1)Radioimmunoassayofserum17-OH-progesteronefordiagnosisandtreatmentofcongenitaladrenalhyperplasia)5.關(guān)節(jié)鏡(arthroscopy)輔助治療掌指關(guān)節(jié)內(nèi)骨折(metacarpophalangealintraarticularfractures)Treatmentofmetacarpophalangealintraarticularfractures(assisted)witharthroscopyAssignment(Chapter1)MedicalEnglishWriting(2)WritingaresearchpaperPartsofamanuscriptTitleAbstract(andkeywords)IntroductionMethodsResultsDiscussionAcknowledgementsReferencesFiguresTablesLegends

IMRADBasicstyle:introduction,methods,resultsanddiscussionServesasanorganizationalformatIMRADisaformat,eachpaperdiffersHistoryofIMRADOriginallyproposedbytheBritishscientistBradfordHillDevelopedbybyFrenchchemistLouisPasteurEstablishedbyAmericanStandardsInstitutein1972Developedin1978byateamofmedicaljournal

editorsduringameetinginVancouver(溫哥華),

CanadaTheteamdevelopedintotheInternationalCommittee

ofMedicalJournalEditors(ICMJE國際醫(yī)學雜志編輯委員會),whichproposedTheUniformRequirements

forManuscripts

SubmittedtoBiomedicalJournals

(URMSBJ生物醫(yī)學雜志投稿統(tǒng)一要求)Introduction——ContentsBackground:StatementofgeneralareaorhistoryofproblemSignificance:StatementofimportanceorneedsDevelopment:Statementofpreviousfindings,reportsorstudiesObjective:StatementofpurposeofcurrentstudyScope:statementofspecificareaofproblemtobestudiedIntroduction——RequirementsGostraighttothepoint開門見山Laystressonthekeypoints重點突出Bepracticalandrealistic實事求是

Aguidingprinciple引導作用Knowninformationingeneral↓Unknowninformation↓Question↓ApproachIntroduction

begintotellastory

1 Beginwithwhatisknown(A) 2 Statewhatisunknown(B) 3 Statethequestionwhatyourstudywillanswer(C)4Describetheexperimentalapproach(D)OptimalMedicalTherapywithorwithoutPCIforStableCoronaryDisease

WilliamE.Boden,M.D.,NENGLJMED2007;Vol.356No.15Duringthepast30years,theuseofpercutaneouscoronaryintervention(PCI)hasbecomecommonintheinitialmanagementstrategyforpatientswithstablecoronaryarterydiseaseinNorthAmerica,eventhoughtreatmentguidelinesadvocateaninitialapproachwithintensivemedicaltherapy,areductionofriskfactors,andlifestyleintervention(knownasoptimalmedicaltherapy).In2004,morethan1millioncoronarystentprocedureswereperformedintheUnitedStates,andrecentregistrydataindicatethatapproximately85%ofallPCIproceduresareundertakenelectivelyinpatientswithstablecoronaryarterydisease.

PCIreducestheincidenceofdeathandmyocardialinfarctioninpatientswhopresentwithacutecoronarysyndromes,butsimilarbenefithasnotbeenshowninpatientswithstablecoronaryarterydisease.Thisissuehasbeenstudiedinfewerthan3000patients,manyofwhomweretreatedbeforethewidespreaduseofintracoronarystentsandcurrentstandardsofmedicalmanagement.(A)AlthoughsuccessfulPCIofflow-limitingstenosesmightbeexpectedtoreducetherateofdeath,myocardialinfarction,andhospitalizationforacutecoronarysyndromes,previousstudieshaveshownonlythatPCIdecreasesthefrequencyofanginaandimprovesshort-termexerciseperformance.Thus,thelong-termprognosticeffectofPCIoncardiovasculareventsinpatientswithstablecoronaryarterydiseaseremainsuncertain.(B)Ourstudy,theClinicalOutcomesUtilizingRevascularizationandAggressiveDrugEvaluation(COURAGE)trial,wasdesignedtodeterminewhetherPCIcoupledwithoptimalmedicaltherapyreducestheriskofdeathandnonfatalmyocardialinfarctioninpatientswithstablecoronaryarterydisease,ascomparedwithoptimalmedicaltherapyalone.(C)(D)Tenses

Simplepresenttense:表述真實的、普遍認可的研究結(jié)果或研究結(jié)果的提示。或提出問題presentperfecttense:表述研究現(xiàn)狀Pasttense:表述發(fā)現(xiàn)的內(nèi)容及過去考慮過或做過的內(nèi)容,或未定論的研究結(jié)果,或研究導向的目的CommonSentencePatterns

引用文獻資料:sb.(sb.etal)found/reported/described/mentioned/showedthatsth.wasfound/reported/mentionedbysb.Ithasbeenreported/demonstrated/observedthat

表達不同觀點和意見:…studieshavedifferedintheirconclusionon/about/regarding…Therehasbeendifferent/conflictingreportson…Therehasbeenconsiderableprofessionaldebateon/about…Therehasbeencontroversiesover/conflictingresultsabout/on…表示尚待解決的問題:Littleworkhasbeendoneon…Relativelylittleknowledgeisavailablerelatedto…Littleattentionhasbeenpaid/givento…Itisunclear/uncertain/unknownwhether……is/remainscontroversial/unexplored/unclear/unknown/difficult…表示本研究的重要性:…h(huán)aspracticalsignificance/implicationfor……h(huán)asbeenthesubjectofintensiveresearch…h(huán)asbeenthefocusofmuchinterestanddebate.表示研究的內(nèi)容和目的:Thepurpose/objective/aim/goalofthisstudy/investigationis/wasto…Thisstudyaimedto…Thisstudywasdesigned/undertaken/performed/conducted/carriedoutto…Thepresentstudywasundertakento…Thestudyherereportedwasundertakento…Thisstudywas…Inanattempttodetermine/assess/investigateto…Inaneffortto/inorderto…Inthisstudy,weattempted/aimed/soughtto…MaterialandMethods

Writethissectionfirst!HowwastheproblemstudiedUsuallyarrangedchronologicallyreadslikeacookbook,toprovideenoughdetailsandreferencematerialsfortheotherresearcherstoevaluateandrepeatthepresentstudyMaterialandMethods——Contents1)簡要說明研究設(shè)計(studydesign/protocol),如:回顧(retrospective/review),前瞻(prospective),臨床(clinical),動物(animal),實驗

(experimental),活體內(nèi)(invivo)活體外(invitro),原位(insitu),隨訪(follow-up),對照(controlled),隨機)random/randomized),雙盲交叉(double-

blindcrossover),人群(population/cohort/

migrant),對比(comparative),流行病學

(epidemiological)等研究性質(zhì);

MaterialandMethods——Contents

2)詳細說明研究對象(subject)情況,包括動物

(animal)和病人(patients)性別(sex)、年齡(age)、物種(species)、品種(breed)、生理狀態(tài)

(physiologicalstate);微生物菌株(strain)、血清型(serotype)及其他區(qū)別特性(identity

characteristics);隨機分組方法(methodsofany

randomassignmentofsubjectstogroups)和選擇標準(criteriaforadmissiontostudygroups);MaterialandMethods——Contents3)詳細說明所用的藥物(drug),激素(hormone),試劑(reagent)和其他化學品(chemical)的名稱、商標(trademark)、生產(chǎn)廠家(manufacturer)及所在地(location);4)簡要說明測定方法(methodofmeasurement),包括名稱,引文(quotation)和偏差(variations);5)簡要說明統(tǒng)計學分析方法(methodof

statisticanalysis)WritingdetailsUsesubheadings,payattentiontothecoherenceUsetables(e.g.,patientcharacteristics)andfigures(e.g.,analysisofdata)toclarifyExplainlimitationsinbriefLastparagraphisstatisticalanalysis -howdataaresummarized,statisticaltest,measurementscompared,PvalueWriteinpasttensegenerallyUsebothfirstpersonorthirdperson(morecommon)CommonSentencePatterns選擇研究對象:Inclusion/Entry/Exclusioncriteriawere/included…Selectionwasbasedon…,…wereselectedbasedon…Themajorcriteriaforinclusioninthestudywere……wereenteredinto/recruitedfrom/selectedfrom/enrolledat……wereexcludedfromthestudy/participation表示研究對象分組:…weredivided/grouped/stratified/classified/categorized/assigned/randomizedinto………wererandomlyallocatedto…(basedon…)表示材料來源:1.…was(obtained)from…2.…wasprovidedby…3.…waspurchasedfrom…4.…wasdonatedby/adonationfrom/agiftfrom…5.…(sourcesofmaterial)表示實驗動物:…werebredin/fed/maintained/raisedwith/under……werefasted/starved12hourspriortooperation.…wereanesthesizedwith……werecaged,fed,adlibitumwithtapwaterand…diet…weighing…and…wereusedforthestudy.…werekilledbydecapitation/cervicaldislocation(斷頭)/exsanguination(放血).…weresacrificedwith…表示借鑒他人的實驗方法:…wasisolated/separatedbytheprocedure/techniqueof……wasprepared/carriedout

accordingtothemethoddescribedby……wasdeterminedby/measuredwith…表示稀釋、培養(yǎng)…wasdilutedto……incubatedwith…at

…℃(temperature)for…h(huán)ours.…wasgrownin…medium…wassuspendedto/ataconcentrationof……wasstoredat…℃(temperature)表示實驗標本制備:Samplesof/for…wereobtained/takenfrom……werecollected/harvestedunder…conditions.…werefixed(固定)with/in……werestained(染色)with……wereembedded(包埋)in/with……wereprepared…weredehydrated(脫水)in/by……weresectionedatathicknessof…表示診斷和治療:…wasdiagnosedby/diagnosticof……wasdiagnosedas/with…(accordingto/onthe

basisof…)3.Diagnosisof…wasconfirmed/made/established.4.…miss/overlookdiagnosis(漏診)of…5.…wasmisdiagnosedas/wasmistakenfor(誤診)…6.…betreatedby…7.…betreatedfor…8.…wason…therapy9.…wasreferred/transferred

toResults

whatwerethefindingsFunctions:stateresultsofthestudy andpresentdatathatsupportsresultsContents:resultsanddataOrganization:chronologicalorfrommosttoleastimportantWritingdetailsBebriefanduncluttered,usesubheadingsUsepasttensegenerallyGivespecificcomparisonsPresentdetaileddatainfiguresandtablestokeepwrittendatatoaminimumProvideappropriatestatisticaldetailswithoutcommentsCommonSentencePatterns結(jié)果表明:Theresults/findingsshowed/suggested/indicated/demonstrated/revealed/documentedthat…Itwasfoundthat…Wefoundthat……was/werefoundto…表格與插圖的表達:…isshown/presentedinTable/Figure…Table/Figure…shows/indicates/demonstrates/illustratesthat…AsshowninTable/Figure…表示與…有關(guān):…wasstronglyassociatedwith……wasinverselycorrelatedwith……wasinversely/indirectlyproportionalto……wasindirectproportionto……wascomparedto/with…;ascomparedwith/to…數(shù)值表達:…wasincreased/decreasedby/to…多數(shù)值表達,常采用逗號、分號或括號隔開表示數(shù)量的一部分,用of,outof,among等介詞直接用數(shù)字形式及符合,如“+”“-”“×”“÷”“=”“≤”“≥”等表示數(shù)字對比如:”ratio”“:”“/”“versus/vs/v.”“rate”表示數(shù)值范圍:(range)from…to…/between…and…,varyfrom…to…,witharange…to…,表達統(tǒng)計學意義:Thereis/was

significantdifferencein…between…and…Thedifferencein…between…and…is/was

significant…is/was

significantlydifferencefrom…Nosignificantdifferencewasfound/noted/observedin…between…and…

Discussion

whatdoyourfindingsmeanMostdifficultPart!AnswerthequestionposedinIntroductionExplainhowresultssupportanswersandhowanswersfitwithexistingknowledgeonthetopicExplainthefindings,relationships,andgeneralizationsofyourresultsExplainthesignificanceofyourresultsHasabeginning,middle,andendReqDiscussion——Contents1).background2).generalfindings3).introductionofpoints4).comparisoninthecontextofotherstudies5).suggestedmeaning6).conclusion7).futurestudiesCommonSentencePatternsThedata/resultssuggest/demonstrate

/confirm/indicate/revealthat…2.…experiments/results/findings/investigation/

factssupplyabasisfor…3.Theresultsareconsistent/inaccordwiththe

theory/idea/proposal/hypothesis/pervious

studiesthat…4.…similartothatreported/describedby…CommonSentencePatterns5.Resultsarecontrastedwith/differentfrom…6.…mayhavecausedby…7.…mayleadto/resultin/accountfor…8.Although/Evenif…,itshould(not)be

possibleto…9.Oneinterpretationofthisdifference

between…and…is…10.Onthebasisof/basedonthesepremises…11.Wecanspeculateon…12.Whether…remains/isyettobedetermined…13.

Furtheranalysis/experimentswillbe

necessary/neededtoconfirm…14.

Weconcludethat/ourconclusionisthat/itis

ourconclusionthat…15.

insummary/inconclusion,…16.….haveimplicationsfor…CommonSentencePatterns17.

Thereareseverallimitationsto…;thereis

ofsome/littlevaluein/to…18.

Thereisofgreatsignificancein…19.

Inourexperience/practice20.

Asweknow/asfarasweknow/toour

knowledge…21.

Fromourresults/findings22.

Amajornewfindingofthisstudyisthat…CommonSentencePatternsReferencesImportantpartofaresearchpaperandareviewMorereferences(15-100)ChoosetheauthenticreferencesThereferencescanreflectthelevelandvalueoftheresearchpaperandreviewstylesshouldbespecifictoeachjournal

標準期刊文獻HalpernSD,UbelPA,CaplanAL.Solid-organtransplantationinHIV-infectedpatients.NEnglJMed.2002Jul25;347(4):284-7.

著者:姓前名后,名縮寫,以逗號分隔文章標題期刊名(標準縮寫),年,月,日;卷,期:頁TipsKnowthejourna

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論